These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29695321)

  • 1. Increased number of tissue factor protein expressing thrombocytes in canine idiopathic immune mediated hemolytic anemia.
    Hennink I; van Leeuwen MW; Penning LC; Piek CJ
    Vet Immunol Immunopathol; 2018 Feb; 196():22-29. PubMed ID: 29695321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High intravascular tissue factor expression in dogs with idiopathic immune-mediated haemolytic anaemia.
    Piek CJ; Brinkhof B; Teske E; Rothuizen J; Dekker A; Penning LC
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):346-54. PubMed ID: 21899896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microparticle-associated tissue factor activity in dogs with disseminated intravascular coagulation.
    Kobayashi K; Baba K; Igase M; Miyama TS; Kambayashi S; Okuda M
    J Vet Med Sci; 2020 Jan; 82(1):56-60. PubMed ID: 31787663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs.
    Carr AP; Panciera DL; Kidd L
    J Vet Intern Med; 2002; 16(5):504-9. PubMed ID: 12322697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant canine interleukin-6 and interleukin-8 on tissue factor procoagulant activity in canine peripheral blood mononuclear cells and purified canine monocytes.
    Ogasawara S; Daddona JL; Trimpert J; Stokol T
    Vet Clin Pathol; 2012 Sep; 41(3):325-35. PubMed ID: 22724392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation.
    Andreasen EB; Nielsen OL; Tranholm M; Knudsen T; Kristensen AT
    Vet Comp Oncol; 2016 Jun; 14(2):191-201. PubMed ID: 24674618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus-type "anticoagulant" in a dog with hemolysis and thrombosis.
    Stone MS; Johnstone IB; Brooks M; Bollinger TK; Cotter SM
    J Vet Intern Med; 1994; 8(1):57-61. PubMed ID: 8176665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor procoagulant activity in the tumor cell lines and plasma of dogs with various malignant tumors.
    Kobayashi K; Baba K; Igase M; Primarizky H; Nemoto Y; Shimokawa Miyama T; Kambayashi S; Mizuno T; Okuda M
    J Vet Med Sci; 2019 Dec; 81(12):1713-1721. PubMed ID: 31611484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procoagulant microparticles in dogs with immune-mediated hemolytic anemia.
    Kidd L; Geddings J; Hisada Y; Sueda M; Concannon T; Nichols T; Merricks E; Mackman N
    J Vet Intern Med; 2015; 29(3):908-16. PubMed ID: 25871966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation.
    Wiinberg B; Jensen AL; Johansson PI; Rozanski E; Tranholm M; Kristensen AT
    J Vet Intern Med; 2008; 22(2):357-65. PubMed ID: 18346141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of platelet activation in canine immune-mediated haemolytic anaemia.
    Ridyard AE; Shaw DJ; Milne EM
    J Small Anim Pract; 2010 Jun; 51(6):296-304. PubMed ID: 20618628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine idiopathic immune-mediated haemolytic anaemia: a review with recommendations for future research.
    Piek CJ
    Vet Q; 2011 Sep; 31(3):129-41. PubMed ID: 22029883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the immune system and thrombosis.
    Johnson LR
    J Vet Intern Med; 2002; 16(5):501-3. PubMed ID: 12322696
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia.
    Scott-Moncrieff JC; Treadwell NG; McCullough SM; Brooks MB
    J Am Anim Hosp Assoc; 2001; 37(3):220-7. PubMed ID: 11361112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia.
    Takatu A; Nash RA; Zaucha JM; Little MT; Georges GE; Sale GE; Zellmer E; Kuhr CS; Lothrop CD; Storb R
    Biol Blood Marrow Transplant; 2003 Nov; 9(11):674-82. PubMed ID: 14652850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of canine parvovirus on erythroid progenitors in phenylhydrazine-induced regenerative hemolytic anemia in dogs.
    Brock KV; Jones JB; Shull RM; Potgieter LN
    Am J Vet Res; 1989 Jun; 50(6):965-9. PubMed ID: 2548423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudohypophosphatemia in two dogs with immune-mediated hemolytic anemia.
    Harkin KR; Braselton WE; Tvedten H
    J Vet Intern Med; 1998; 12(3):178-81. PubMed ID: 9595380
    [No Abstract]   [Full Text] [Related]  

  • 18. Dogs cast NETs too: Canine neutrophil extracellular traps in health and immune-mediated hemolytic anemia.
    Jeffery U; Kimura K; Gray R; Lueth P; Bellaire B; LeVine D
    Vet Immunol Immunopathol; 2015 Dec; 168(3-4):262-8. PubMed ID: 26574161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-endothelial cell antibodies in dogs with immune-mediated hemolytic anemia and other diseases associated with high risk of thromboembolism.
    Wells R; Guth A; Lappin M; Dow S
    J Vet Intern Med; 2009; 23(2):295-300. PubMed ID: 19192144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenectomy as adjunctive therapy for immune-mediated thrombocytopenia and hemolytic anemia in the dog.
    Feldman BF; Handagama P; Lubberink AA
    J Am Vet Med Assoc; 1985 Sep; 187(6):617-9. PubMed ID: 4086369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.